Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 858

PDF Downloaded: 663


Get Permission Mehta, Punjabi, and Bedi: Prevalence of diabetic retinopathy: A tertiary care centre based study


Introduction

The number of people affected by diabetes all over the world was 424.9 million in the year 2017.1 It is estimated to increase to a huge 628 million by the year 2045.2 Diabetes is a multisystem metabolic disorder that affects not only heart, kidney and brain but also eyes.3, 4 While diabetes can affect different structures within the eye such as cornea, lens, extraocular muscles and optic nerve, the most severe and debilitating visual disorder is caused by retinal involvement.5 The involvement of retina in diabetes is called diabetic retinopathy (DR). DR is a leading cause of blindness across the globe.6, 7 DR is known to inflict the eye in a wide spectrum from clinically significant macular oedema to vitreous hemorrhage and retinal detachment. These complications of DR are progressive in nature and if not treated on time can lead to irreversible blindness.8

Since the global prevalence of diabetes is estimated to rise exponentially, the prevalence of DR is also bound to rise. Consequently, a large population will be at risk by DR in near future. Therefore we conducted a study to find out the current prevalence of DR amongst the people suffering from diabetes.

Materials and Methods

A cross sectional observational study was conducted at Geetanjali Medical College and Hospital, Udaipur, from July 2018 to June 2019. Permission for this study was taken from the institutional ethics committee and informed consent was obtained from all the patients.

Inclusion criteria

All the consenting patients attending the outdoor at department of medicine and diagnosed with diabetes were enrolled for the study.

Exclusion criteria

Patients with corneal opacity and /or cataract which obscured the detailed examination of fundus view were excluded.

After taking demographic details of age and gender, clinical history, duration of diabetes and details of treatment, all eligible patients underwent a complete ophthalmic examination which included visual acuity by Snellen’s chart and slit lamp biomicroscopy. Fundus was examined by an ophthalmologist with more than 15 years of experience (RM). Indirect ophthalmoscopy was done by +90D and +20 D lenses. Fundus drawing was recorded diagrammatically. The DR was classified into Non –Proliferative DR (NPDR) and Proliferative DR (PDR) according to Early Treatment Diabetic Retinopathy Study (ETDRS) criteria.9 NPDR was further classified into mild, moderate, severe and very severe according to ETDRS criteria.

The data was entered in MS excel sheet and statistical analysis was done by Statistical Program for Social Sciences (SPSS) version 21.0.0.0. The association with age, sex and duration of diabetes was analysed by Chi –square test and considered significant for p <0.05.

Results

A total of 314 patients with diabetes were enrolled for the study. Of them 23 were found to have media opacity of such a density so as to obscure the fundus views which were excluded. Of them 11 were having cataract and 12 were having corneal opacity. Finally 291 patients were found to be eligible for the study. Of the 291 patients 159 (55%) were males. The age of males ranged from 29 to 86 years (mean =59.36 years). The age of females ranged from 33 to 82 years (mean=58.23 years).

The number of patients affected by DR among 291 patients was 76 (26.11%) of which 43 were males.

Table 1

Distribution of diabetes according to gender

Patients with Diabetes Percentage
Male 159 55%
Female 132 45%
Total 291

[i] (p>0.05)

Table 2

Distribution of diabetes with age

Duration of Diabetes
< 5 year 5-10 years >10 years
Male 53 67 39
Female 46 59 27
Total 99 126 66

[i] (p<0.05)

Table 3

Duration wise distribution of prevalence of DR

Duration of Diabetes
< 5 year (n=99) 5-10 years (n=126) >10 years(n=66) Total (%)
Male 3 16 24 43 (56.57)
Female 2 14 17 33(32.89%)
Total 5 (5%) 30 (23.8%) 41(62.12%) 76 (100%)

[i] (p<0.05)

Prevalence of DR for duration less than 5 years was 5% (p <0.05), for a duration of 5-10 years was 23.8% (p <0.05), and for a duration of >10 years was 62.12% (p <0.05).

Table 4

Age wise distribution of prevalence of DR

Age (years) DR Prevalence (%)
Present Absent Total
<40 1 41 42 2%
40-60 32 94 126 25%
60-80 34 80 114 30%
>80 9 0 9 100%
Total 76 215 291 26.11%

[i] (p <0.05)

Table 5

Prevalence of DR according to visual acuity

DR Prevalence (%)
Present Absent Total
>6/12 24 64 88 27%
6/24-6/12 25 69 94 27%
6/60- 6/24 21 79 100 21%
<6/60 6 3 9 67%
Total 76 215 291

[i] (p< 0.05)

Table 6

Prevalence of DR according severity of DR (n=76)

Severity of DR Prevalence (%)
Mild NPDR 39 51.31
Moderate NPDR 17 22.36
Severe NPDR 13 17.1
PDR 7 9.2
Total 76
Table 7

Prevalence of severity DR according to duration of Diabetes (n=76)

Duration of Diabetes
< 5 year 5-10 years >10 years(n=76) Total
Mild NPDR 5 30 4 39
Moderate NPDR 0 0 17 17
Severe NPDR 0 0 13 13
PDR 0 0 7 7
Total 5 (6.57%) 30 (39.47%) 41(53.94%) 76 (100%)

[i] (p <0.01)

Table 8

Prevalence of severity DR according to age of diabetics (n=76)

Age (Years)
<40 40-60 60-80 >80 Total
Mild NPDR 1 20 18 0 39
Moderate NPDR 0 6 7 4 17
Severe NPDR 0 4 7 2 13
PDR 0 2 2 3 7
Total 1(1%) 32 (42.1%) 34(44.73%) 9(11.8%) 76

[i] (p <0.05)

Figure 1

Prevalence of DR according to its severity

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/28b4c703-937a-47db-b4b0-02c89a78e7e9/image/d777a208-7ed4-4c8b-bfaf-3dbad8b6f88f-uimage.png

Discussion

Several studies have found the prevalence of DR in India to vary from 17.6% to 28.2%.10, 11, 12, 13 this huge variation of the figure in different studies is very confusing. The prevalence of DR in our study was found to be 26.11% (Table 4) which is on the higher side as compared to other studies. This difference in the figures could be due to different types of lifestyles, dietary habits and access to health care across the globe. One of the major confounding factors can be the different kind of design of each study thereby inducing sampling errors. We have tried to keep our study simple and precise, thereby leading to easy and straightforward interpretation of the data.

In our study, DR was found in 43 (56.57%) males and 33 (32.89%) females. This distribution was not found to be statistically significant (p>0.05).

The prevalence of DR was found to be increasing with the duration of diabetes. The prevalence of DR increased from just 5% for duration of diabetes less than 5 years to 62% for duration of more than 10 years (Table 3) This association was found to be significant (p<0.05). It is in concurrence with other studies which also found the same.14, 15, 16

The prevalence of DR increases with age from just 2% below 40 years of age to 100% in more than 80 years of age in our study (Table 4). This association was found to be strongly linked (p <0.05). The severity of DR also increased with age from nil PDR under age of 40 years to 7 cases above the age of 40 years (Table 8). The finding of age as a risk factor is in concurrence with other studies.11, 12, 13, 14

An important observation in this study has been that not all patients found to have DR had loss of visual acuity. Out of 76 patients who were found to have DR, 24 (31.57%) patients had visual acuity of more than 6/12(Table 5). It indicated that the visual acuity could be normal despite the patients developing DR. It also implied that patients with diabetes may remain unaware of development of DR because visual acuity is not affected in all cases. It underlines the importance for regular examination of all the patients with diabetes. The necessity for regular fundus examinations in diabetic patients has also been mention in other studies.12, 13, 14, 15

Our study found that the severity of DR increased with the duration of diabetes. In diabetics of duration of less than 5 years, only 5(6.57%) patients had DR (Table 3). Moreover, all of them had only mild NPDR (Table 7). In diabetics of duration of more than 10 years 41(53.94%) cases of DR were found. Moreover, 13 had severe NPDR and 7 had PDR. This association of severity of DR with duration was found to be strongly linked (p<0.01). Longer duration of diabetes leads to higher metabolic derangement, thereby increasing the severity of DR.16, 17, 18 It further underlines the importance of regular fundus examinations in diabetic patients.

The limitation of this study is small sample size and hospital based. Therefore the prevalence derived from this study cannot be accurately extrapolated to entire population of the country. Hence, a large population based study with randomized sampling is recommended.

Conclusion

The prevalence of DR is very high in Indian population. DR patients can have normal visual acuity in early stages. The severity of DR rises with increase in duration of diabetes. Therefore regular ophthalmic examination of all diabetics is recommended to diagnose DR at early stages.

Source of Funding

None.

Conflict of Interest

None.

References

1 

S Wild G Roglic A Green R Sicree H King Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030Diabetes Care2004275104753

2 

G Danaei M M Finucane Y Lu G M Singh M J Cowan C J Paciorek National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsLancet201137897853140

3 

K M V Narayan M K Ali J P Koplan Global Noncommunicable Diseases — Where Worlds MeetN Engl J Med20103631311968

4 

C D Mathers D Loncar Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Med2006311e442

5 

World Health Organization. Global Status Report on Non Communicable Diseases 2010. Geneva: World Health Organization; 2011

6 

J E Shaw R A Sicree P Z Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030Diabetes Res Clin Pract2010871414

7 

R Klein M D Knudtson K E Lee R Gangnon B E K Klein The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetesOphthalmol200811511185968

8 

R W Beck A R Edwards L P Aiello N M Bressler F Ferris A R Glassman Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edemaArch Ophthalmol200912724551

9 

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmol198794776174

10 

S K Pandey V Sharma World Diabetes Day 2018: Battling the Emerging Epidemic of Diabetic RetinopathyIndian J Ophthalmol2018661116523

11 

L Dandona R Dandona T J Naduvilath C A McCarty G N Rao Population based assessment of diabetic retinopathy in an urban population in southern IndiaBr J Ophthalmol199983893740

12 

M Rema S Premkumar B Anitha R Deepa R Pradeepa V Mohan Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, IInvestig Opthalmol VisSci2005467232833

13 

V Narendran R K John Raghurama R D Ravindran P K Nirmalan R D Thulasiraj Diabetic retinopathy among self reported diabetics in Southern India: A population based assessmentBr J Ophthalmol20028610148

14 

S S Gadkari Q B Maskati B K Nayak Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening StudyIndian J Ophthalmol2014643844

15 

A Das Diabetic retinopathy: Battling the global epidemicIndian J Ophthalmol20166423

16 

R Raman L Gella S Srinivasan T Sharma Diabetic retinopathy: An epidemic at home and around the worldIndian J Ophthalmol20166416975

17 

A Giloyan T Harutyunyan V Petrosyan The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional studyBMC Ophthalmol201515146

18 

R Raman K Vaitheeswaran K Vinita T Sharma Is Prevalence of Retinopathy Related to the Age of Onset of Diabetes? Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Report No. 5Ophthal Res20114513641



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

383-386


Authors Details

Rishi Mehta, Sharda Punjabi, Nutan Bedi


Article Metrics


View Article As

 


Downlaod Files